Oxford Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Oxford Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,096	Closed	-$1.85M	–	1422
2019 Q4	$1.85M	Sell	21,096 -8,733	-29%	-$737K	0.05%	463
2019 Q3	$2.25M	Buy	29,829 +5,590	+23%	+$454K	0.05%	473
2019 Q2	$2.07M	Buy	24,239 +3,928	+19%	+$389K	0.04%	628
2019 Q1	$2.19M	Buy	20,311 +2,307	+13%	+$230K	0.05%	527
2018 Q4	$1.52M	Buy	18,004 +245	+1%	+$23.6K	0.04%	628
2018 Q3	$1.74M	Sell	17,759 -4,057	-19%	-$439K	0.04%	740
2018 Q2	$2.51M	Buy	21,816 +4,878	+29%	+$536K	0.05%	529
2018 Q1	$1.67M	Buy	16,938 +538	+3%	+$54.5K	0.04%	673
2017 Q4	$1.72M	Buy	+16,400	New	+$1.8M	0.04%	659

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Oxford Asset Management's TARO Position: Q1 2020 in Review

Oxford Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 21,096 shares — an estimated $1.85M sold.

Oxford Asset Management first reported a position in TARO in Q4 2017 and held it in 9 quarters. The position peaked at $2.51M in Q2 2018. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

Oxford Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 21,096 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $1.85M.
Oxford Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 9 quarters.
Oxford Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $2.51M in Q2 2018.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.